PHATHOM PHARMACEUTICALS
Phathom Pharmaceuticals, launched in 2019 by Frazier Healthcare Partners and Takeda Pharmaceuticals, is a biopharmaceutical company focused on the development and commercialization of novel treatments for gastrointestinal (GI) diseases and disorders. The company is advancing the clinical drug candidate vonoprazan, a novel potassium-competitive acid blocker (P-CAB). Vonoprazan has the potential to address multiple unmet needs among patients with gastroesophageal reflux disease (GERD) and other acid-related disorders. Phathom has assembled a leading team of seasoned gastrointestinal and pharmaceutical industry experts with proven experience developing and commercializing highly innovative therapies.
PHATHOM PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Pharmaceutical
Founded:
2018-01-01
Address:
Florham Park, New Jersey, United States
Country:
United States
Website Url:
http://www.phathompharma.com
Total Employee:
11+
Status:
Active
Contact:
(650) 325-5156
Email Addresses:
[email protected]
Total Funding:
340 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Global Site Tag Mobile Non Scaleable Content Sitelinks Search Box
Similar Organizations
Accent Therapeutics
Accent Therapeutics is a biopharmaceutical company.
Amryt Pharma
Amryt Pharma creates and delivers innovative treatments to help patients with rare and orphan diseases live better lives.
Arkuda Therapeutics
Arkuda Therapeutics is a pharmaceutical company.
Cerevel Therapeutics
Cerevel Therapeutics is a biopharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Corvus Pharmaceuticals
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.
Nuvation Bio
Nuvation Bio is a biopharmaceutical company.
Nymox Pharmaceutical
Nymox Pharmaceutical is a biopharmaceutical company.
Ocugen
Ocugen is a clinical stage biopharmaceutical company.
ORIC Pharmaceuticals
ORIC Pharmaceuticals operates as a biopharmaceutical company.
Osmotica Pharmaceutical
Osmotica Pharmaceutical is a global specialty pharmaceutical company.
SciClone Pharmaceuticals
SciClone Pharmaceuticals is a pharmaceutical company.
Thetis Pharmaceuticals
Thetis Pharmaceuticals is a biopharmaceutical company.
Zhaoke Ophthalmology Pharmaceutical
Zhaoke Ophthalmology Pharmaceutical is a Pharmaceutical platform.
Zomedica
Zomedica is a veterinary pharmaceutical company.
Current Employees Featured
Founder
Stock Details
Investors List
Hercules Capital
Hercules Capital investment in Post-IPO Debt - Phathom Pharmaceuticals
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Private Equity Round - Phathom Pharmaceuticals
Silicon Valley Bank
Silicon Valley Bank investment in Debt Financing - Phathom Pharmaceuticals
Abingworth
Abingworth investment in Private Equity Round - Phathom Pharmaceuticals
Catalys Pacific
Catalys Pacific investment in Private Equity Round - Phathom Pharmaceuticals
Janus Henderson Investors
Janus Henderson Investors investment in Private Equity Round - Phathom Pharmaceuticals
Medicxi
Medicxi investment in Private Equity Round - Phathom Pharmaceuticals
RA Capital Management
RA Capital Management investment in Private Equity Round - Phathom Pharmaceuticals
Greenspring Associates
Greenspring Associates investment in Private Equity Round - Phathom Pharmaceuticals
Biotechnology Value Fund
Biotechnology Value Fund investment in Private Equity Round - Phathom Pharmaceuticals
Key Employee Changes
| Date | New article |
|---|---|
| 2022-03-22 | Phathom Pharmaceuticals Announces Appointment of Molly Henderson as Chief Financial and Business Officer |
| 2020-01-06 | Phathom Pharmaceuticals names chief commercial officer |
Official Site Inspections
http://www.phathompharma.com Semrush global rank: 4.13 M Semrush visits lastest month: 2.9 K
- Host name: 95.70.73.34.bc.googleusercontent.com
- IP address: 34.73.70.95
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Phathom Pharmaceuticals"
About Us - Phathom Pharmaceuticals
Paul Cocja is the former Vice President, People and Organization for Novartis’ U.S. Pharmaceutical Division and most recently led their U.S. Transformation Office. He has over 35 years of Human Resources (HR) experience, the …See details»
Life at Phathom - Phathom Pharmaceuticals
At Phathom, we consider each other as “Phamily.” We are a team of highly driven pharmaceutical professionals who are passionate about our mission to improve the lives of people suffering …See details»
Phathom Pharmaceuticals - Crunchbase Company …
Contact Email [email protected] Phone Number (650) 325-5156 Phathom Pharmaceuticals, launched in 2019 by Frazier Healthcare Partners and Takeda Pharmaceuticals, is a biopharmaceutical company focused on the …See details»
Phathom Pharmaceuticals - LinkedIn
Phathom Pharmaceuticals (Nasdaq: PHAT) is a biopharmaceutical company committed to transforming the treatment landscape for people suffering from gastrointestinal (GI) diseases related to acid.See details»
Investors & Media | Phathom Pharmaceuticals, Inc.
Oct 28, 2024 Net revenues of $16.4 million reported for the third quarter 2024 compared to $7.3 million in the second quarter 2024, over 120% sequential quarterly increase Over 143,000 …See details»
Phathom Pharmaceuticals, Inc. Company Information - Drugs.com
Jun 12, 2023 Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided …See details»
News Release - Phathom Pharmaceuticals, Inc.
May 10, 2022 General and administrative expenses for the first quarter ended March 31, 2022 increased to $20.2 million compared to $13.0 million for first quarter 2021 primarily due to the …See details»
Phathom Pharmaceuticals Company Overview, Contact Details
Aug 19, 2024 [email protected]: 1%. See more formats. Frequently Asked Questions Where is Phathom Pharmaceuticals 's headquarters located? Phathom Pharmaceuticals 's …See details»
Phathom Pharmaceuticals - Craft
Oct 28, 2024 Phathom Pharmaceuticals is a biopharmaceutical company focused on treating gastrointestinal diseases and disorders. The company offers Vonoprazan, a small molecule …See details»
Connect With Us – Phathom Pharmaceuticals
For general inquiries, please contact [email protected] or call +1-(877)-742-8466. Medical Information. Report an Adverse Event or Product Complaint. Please call +1-(888)-775 …See details»
Overview, News & Similar companies - ZoomInfo.com
May 27, 2024 Who is Phathom Pharmaceuticals. Phathom Pharmaceuticals is a late clinical-stage biopharmaceutical company focused on developing and commercializing new …See details»
Phathom Pharmaceuticals Reports Fourth Quarter and Full Year …
Mar 7, 2024 [email protected]. INVESTOR CONTACT Eric Sciorilli 1-877-742-8466 [email protected]. Selected Condensed Balance Sheets (in thousands) December 31, …See details»
Our Science - Phathom Pharmaceuticals
Phathom Pharmaceuticals is working to change the GI treatment landscape and improve the lives of patients with acid-related disorders.See details»
Phathom Pharmaceuticals Reports First Quarter 2024 Financial …
May 9, 2024 [email protected]. Selected Condensed Balance Sheets (in thousands) (unaudited) March 31, 2024 . December 31, 2023. Assets . Cash and cash equivalents $ …See details»
News Release - investors.phathompharma.com
Nov 8, 2021 [email protected]. Investor Contact: Joe Hand 1-877-742-8466 [email protected]. PHATHOM PHARMACEUTICALS, INC. Balance Sheets …See details»
H. pylori - Phathom Pharmaceuticals
Helicobacter pylori (H. pylori) Infection H. pylori is a bacterial pathogen that infects approximately 35% of the U.S. population and 45% of the population in the five major countries in Europe …See details»
Phathom Pharmaceuticals Reports Fourth Quarter and Full Year …
FLORHAM PARK, N.J., March 01, 2022 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and …See details»
Our Products - Phathom Pharmaceuticals
Learn more about Phathom Pharmaceuticals products including VOQUEZNA® (vonoprazan) tablets.See details»
News Release - Phathom Pharmaceuticals, Inc.
Nov 28, 2023 Phathom has in-licensed the exclusive rights in the U.S., Europe, and Canada to vonoprazan, a first-in-class potassium-competitive acid blocker (PCAB). For more information …See details»